The directors of biotechnology company Botry-Zen Ltd have resigned, saying there is unlikely to be any assets remaining once receivers have finished their job."The board again expresses its disappointment that, due to a lack of capital, it was unable
The directors of biotechnology company Botry-Zen Ltd have resigned, saying there is unlikely to be any assets remaining once receivers have finished their job.
"The board again expresses its disappointment that, due to a lack of capital, it was unable to see to fruition the good work done, and investment made, by many people over a number of years."
The directors said their resignation would be effective from March 30.
The biotechnology company, which was floated on the New Zealand share market in 1991, was placed in receivership in December.
